Product Benefits

• Balanced Dual Action (50/50): Contains an equal split (50%) of rapid/short-acting insulin for mealtime coverage and intermediate-acting insulin for basal needs, offering highly balanced control.

• High Mealtime Coverage: The significant 50% short-acting component ensures strong and quick insulin action to effectively manage the immediate rise in blood sugar after eating.

• Simplified Injection Regimen: Combines two essential insulin types into one fixed-ratio mix, reducing the number of injections and the complexity of daily dosing preparation.

• Sustained Background Control: The 50% intermediate-acting component provides a reliable, sustained release over time, crucial for stable blood sugar levels between meals and overnight.

• Effective Glucose Management: A highly effective therapeutic option for individuals requiring a substantial proportion of both bolus (mealtime) and basal insulin coverage.

• Standard Concentration: Provided in the globally recognized 100 IU/ml concentration, ensuring familiarity, ease of calculation, and compatibility with standard insulin delivery devices.

• Improved Patient Compliance: The simplicity of the combined, single-injection regimen can lead to better adherence and consistency in the overall diabetes treatment plan.